Updated:
3D Systems
3D Systems provides comprehensive products and services, including 3D printers, print materials, software, on-demand manufacturing services, and healthcare...
3D Systems
3D Systems provides comprehensive products and services, including 3D printers, print materials, software, on-demand manufacturing services, and healthcare solutions.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Rock Hill
Corporate office
Rock Hill, SC, United States
Additional offices
San Francisco, CA · Philadelphia, PA
Sector focus
Frequently asked questions
What is the relationship between 3D Systems as a corporation and any affiliated family-office investment activity?
3D Systems operates as a publicly traded additive manufacturing company, not a family office. The Altss record for this entity reflects the firm for informational completeness, but the firm does not disclose any single-family-wealth management or investment-office function. Entity classification as 'Asset Manager' aligns with its role as a technology and production-asset operator.
How does 3D Systems' healthcare vertical differ from a standard medical-device manufacturer?
The firm uses additive manufacturing to produce patient-specific anatomical models, surgical guides, and implants that are geometrically customized — a process difficult to achieve with traditional subtractive or molding methods. This places the healthcare segment adjacent to digital manufacturing rather than large-scale commodity device production.
Which sectors does 3D Systems explicitly avoid?
There is no publicly documented exclusion list. Observable activity concentrates on industrial manufacturing and regulated healthcare; the firm does not actively participate in consumer-electronics 3D printing, hobbyist filaments, or general software outside its proprietary ecosystem.
Does 3D Systems maintain fund commitments or a direct-investment model for technology ventures?
The firm does not disclose a corporate venture-capital or fund-commitment arm targeting external startups. Research and development appears to channel through internal engineering programs rather than a separate investment vehicle.
What is the firm's known posture on co-investments alongside external industrial partners?
No co-investment club or syndicate structure is publicly documented. The firm licenses technology and sells finished goods directly to manufacturers and healthcare systems rather than forming pooled-capital vehicles with external GPs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: